MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2026 International Congress

    Combination Device-aided therapy in Parkinson’s Disease

    S. Garg, G. Chavira-Hernandez, R. Munhoz, T. Mestre (Ottawa, Canada)

    Objective: To analyse the clinical profile and outcomes of patients with Parkinson’s Disease (PD) on combination Device-Aided Therapies (DAT) of Deep Brain Stimulation (DBS) and…
  • 2026 International Congress

    Association of Benign Prostatic Hyperplasia With Incident Parkinson’s Disease in Men: A Prospective Cohort Study From the UK Biobank

    Y. Yu, X. Zheng, Y. Wang, X. Liu, H. Shang, C. Li (Chengdu, China)

    Objective: To evaluate whether benign prostatic hyperplasia (BPH) is associated with incident Parkinson’s disease (PD) in men and to explore whether BPH-related medications may influence…
  • 2026 International Congress

    Treadmill-Based Backward Walking Training as a Rehabilitation Strategy in People with Parkinson’s Disease: A Feasibility Study

    N. Kumar, M. Natarajan, C. Balasubramanian, A. Prabhu (Udupi, India)

    Objective: To evaluate the feasibility of treadmill-based backward walking training in people with Parkinson’s disease(PwPD) Background: Parkinson’s disease(PD) is a progressive neurodegenerative disorder characterized by…
  • 2026 International Congress

    Caregiver Burden in Advanced versus Non-Advanced Parkinson’s Disease: Strain and Health-Related Quality of Life

    S. Ruohonen, M. Ranta, M. Kalaoja, I. Iso-Mustajärvi, V. Kaasinen (Helsinki, Finland)

    Objective: To compare caregiver burden and health-related quality of life (HRQoL) between caregivers of patients with advanced Parkinson’s disease (aPD) and non-advanced PD (NaPD), and to identify domains contributing to differences…
  • 2026 International Congress

    Understanding the Earliest Phases of Parkinson’s disease: An Update on the Prodromal Effort Within the Global Parkinson’s Genetics Program

    M. Tan, S. Meyer, K. Atterling-Brolin, L. Lange, M. Periñan, S. Waters, C. Gabbert, A. Noyce (Oslo, Norway)

    Objective: To continue recruitment of global ‘at-risk’, early and prodromal Parkinson’s disease (PD) cohorts to the Global Parkinson’s Genetics Program (GP2, http://gp2.org/), support existing cohorts…
  • 2026 International Congress

    Speech Impairment Severity and Motor Symptom Lateralisation in Advanced Parkinson’s Disease

    T. Tienkamp, T. Thies, P. Schumacher, D. Mücke, M. Barbe (Cologne, Germany)

    Objective: To determine whether speech impairment severity, as quantified by acoustic speech measures, is associated with motor symptom lateralisation in advanced Parkinson’s disease (PD). Background:…
  • 2026 International Congress

    Clinical and brain morphological characteristics of patients with Parkinson’s disease and co-occurring apathy and impulse control disorders

    S. Prange, E. Metereau, M. Bereau, H. Klinger, C. Caire, C. Laurencin, D. Devos, M. Anheim, S. Thobois (Bron, France)

    Objective: The aim of this study is to determine the prevalence, clinical and brain MRI morphological characteristics in patients with co-occurring apathy and impulse control…
  • 2026 International Congress

    Are we overlooking wearing off? Evaluating the role of the WOQ-9 questionnaire in routine Parkinson’s care

    G. Heery, B. Mohamed, J. Adenwalla (Cardiff, United Kingdom)

    Objective: 1. Evaluate clinicians’ ability to recognise wearing-off compared with the Wearing Off Questionnaire-9 (WOQ-9)2. Assess patient awareness of wearing-off symptoms Background: Wearing off is…
  • 2026 International Congress

    Association of DAGLB Variants with Early-Onset Parkinson’s Disease Across Populations

    Y. Mecheri, W. Kamel, E. Eltaraifee, A. Olusanya, N. Kuznetsov, GP2. Genetic Program, T. Perinan (Constantine, Algeria)

    Objective: Here, we investigated the contribution of DAGLB variants to PD across diverse ancestries using large-scale data from the Global Parkinson’s Genetics Program (GP2). Background:…
  • 2026 International Congress

    Augmenting PD GENEration Genotyping with Continuous Digital Monitoring for Parkinson’s Disease

    A. Hare, J. Beck, C. Blauwendraat, K. Galvelis, R. Gilron (San Francisco, USA)

    Objective: To link PD GENEration genetic testing and counseling with continuous digital phenotyping to characterize genotype-associated mobility change, reduce access barriers, and support recruitment for…
  • « Previous Page
  • 1
  • …
  • 76
  • 77
  • 78
  • 79
  • 80
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley